Motif Bio Plc (NULL:MTFB) is ranked as a Buy using the Portfolio Grader stock evaluator of Louis Navellier, which incorporates his investing methodology. The shares have been upgraded from a Hold to a Buy in the last week.

Motif Bio Plc (NULL:MTFB) is one of 134 companies within the Pharmaceuticals GICS industry group, which is in turn part of the 781 company GICS Health Care sector. MTFB's market value is $110.2 billion which falls in the top decile in its industry group. The ranking for MTFB by Portfolio Grader places it 48 among the 134 companies in this industry group, putting it in the second quartile; in the top half of the sector with a ranking of 292 among the 781 companies in the sector, and number 1,762 in the nearly 5,000 company Portfolio Grader universe.

Portfolio Grader currently ranks Motif Bio Plc (NULL:MTFB) a Hold. The methods for fundamental and quantitative metrics used in this analytical tool, developed by Louis Navellier researches and ranks nearly 5,000 stocks each week. The shares have been downgraded from a Strong Buy to a Hold in the last week.